Herpes Marker Testing Market - Global Forecast 2026-2032

The herpes marker testing market is experiencing dynamic transformation, shaped by technological innovation, evolving clinical standards, and shifts in global regulatory priorities. For senior decision-makers, this changing landscape offers opportunities to boost growth and operational effectiveness by strategically aligning laboratory processes, clinical workflows, and procurement decisions.

Market Snapshot: Herpes Marker Testing Market Size and Trajectory

The herpes marker testing market posted considerable growth, increasing from USD 531.76 million in 2025 to USD 571.01 million in 2026. Looking ahead, a compound annual growth rate (CAGR) of 7.00% will drive the market to USD 854.10 million by 2032. This upward trajectory is supported by ongoing advances in diagnostic choices and broader adoption by healthcare systems, prompting suppliers and stakeholders to adjust procurement and supply chain models to meet new demand trends.

Scope & Segmentation of the Herpes Marker Testing Market

This report delivers an in-depth analysis of the herpes marker testing market, enabling senior leaders to identify key areas of strategic advantage. Particular attention is paid to segments and drivers critical for procurement planning and operational rollout:

Test Types: Includes combined assays for HSV-1 and HSV-2, and assays dedicated to each strain, shaping how diagnostics direct clinical decision-making and patient engagement.
Technology Modalities: Covers ELISA (IgG, IgM), PCR (Conventional, Real-Time), rapid tests (Lateral Flow, Latex Agglutination), and Western blot. These platforms offer varied workflow integration, sensitivity levels, and suitability for settings ranging from reference labs to point-of-care environments.
End Users: Clinics (both specialized and general), diagnostic labs (independent and hospital-based), hospitals, and research institutes each require adaptive solutions, such as compatibility with laboratory automation or user-centric design for clinics with high patient throughput.
Distribution Channels: Includes direct procurement via government and institutional tenders, hospital and online pharmacies, and retail pharmacy chains, allowing diverse access points and influencing distribution strategy for different end-users.
Regional Markets: Americas, Europe, Middle East & Africa, and Asia-Pacific. Each region reflects distinct procurement, regulatory, and infrastructure profiles, impacting technology adoption and competitive positioning.

Key Takeaways for Decision-Makers

Rising technology diversity is expanding diagnostic solutions, enabling selection from advanced nucleic acid detection, improved immunoassays, and modern rapid tests tailored for both centralized and decentralized use.
Operational needs differ considerably: clinics prioritize quick diagnostics, while laboratories look for higher capacity and automation—affecting product preferences and workflow strategies.
Supply chain and reimbursement protocols are evolving, with procurement practices shifting toward regional vendor contracts and risk-managed sourcing to control costs and improve access reliability.
Heightened focus on regulatory compliance drives manufacturers to enhance assay validation and commit to rigorous post-market surveillance, strengthening product trust and market acceptance.
Integration of herpes marker testing with broader protocols for STI screening and electronic health platforms is becoming more important for hospitals and coordinated care networks, reinforcing the need for connected solutions.
Strategic partnerships, lifecycle management practices, and digital clinician support tools play a growing role in building competitive advantages within the diagnostics value chain.

Tariff Impact: US Policy Changes on Diagnostic Supply Chains

Recent tariff and trade policy updates in the United States are reshaping cost structures and risk profiles for herpes marker testing solution providers with global operations. These changes include higher component costs, encouraging procurement teams to reevaluate ownership expenses and service models. Regional supply chain realignment and increased domestic production aim to limit tariff exposure and strengthen supply security. Laboratories and distributors are adjusting lead times and inventory plans to ensure test availability, while the industry is exploring new local partnerships and consortium purchasing for continuity and resilience.

Methodology & Data Sources

Insights in this report are derived from primary interviews with clinicians, laboratory directors, procurement experts, and senior industry executives. Technical input from assay developers and regulators complements this perspective. Extensive secondary research validates findings against peer-reviewed publications and official documents, ensuring relevance for business and procurement planning.

The Role of Herpes Marker Testing in Diagnostics

Herpes marker testing stands at the intersection of infectious disease diagnostics, supporting the management of acute and latent infections. Technology progress is upping sensitivity and operational efficiencies, while differences in regulatory frameworks and infrastructure influence uptake. For leaders, the focus should remain on integrating these tools into streamlined workflows and enabling adaptable deployment to increase resilience across programs.

Why This Report Matters

Enables senior leaders to align strategic diagnostic investments with rapidly shifting market, regulatory, and operational landscapes.
Provides clear guidance for procurement and adoption by mapping technology features to user and regional requirements.
Equips stakeholders with evidence-based recommendations to address value chain complexity and evolving diagnostics priorities.

Conclusion

Long-term growth in herpes marker testing relies on technology adaptation, flexible deployment, and operational integration. Strategic focus on workflow alignment and evidence-based approaches is key to strengthening market presence and value realization.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Herpes Marker Testing Market, by Test Type

8.1. Combined
8.2. Hsv-1
8.3. Hsv-2

9. Herpes Marker Testing Market, by Technology

9.1. Elisa
9.1.1. Igg Elisa
9.1.2. Igm Elisa
9.2. Pcr
9.2.1. Conventional Pcr
9.2.2. Real-Time Pcr
9.3. Rapid Test
9.3.1. Lateral Flow Assay
9.3.2. Latex Agglutination
9.4. Western Blot

10. Herpes Marker Testing Market, by End User

10.1. Clinics
10.1.1. General Clinics
10.1.2. Specialized Clinics
10.2. Diagnostic Laboratories
10.2.1. Hospital Labs
10.2.2. Independent Laboratories
10.3. Hospitals
10.4. Research Institutes

11. Herpes Marker Testing Market, by Distribution Channel

11.1. Direct Tender
11.1.1. Government Tender
11.1.2. Institutional Tender
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.3.1. Company Websites
11.3.2. E-Commerce Platforms
11.4. Retail Pharmacies

12. Herpes Marker Testing Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Herpes Marker Testing Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Herpes Marker Testing Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Herpes Marker Testing Market
16. China Herpes Marker Testing Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Abcam PLC
17.7. Bio-Diagnostics Ltd.
17.8. Bio-Rad Laboratories, Inc.
17.9. bioMerieux SA
17.10. DiaSorin S.p.A.
17.11. F. Hoffmann-La Roche Ltd.
17.12. Hologic, Inc.
17.13. Luminex Corporation - A DiaSorin Company
17.14. Merck KGaA
17.15. Meridian Bioscience, Inc. by SD Biosensor and SJL Partners
17.16. Norgen Biotek Corporation
17.17. OneCare Media, LLC
17.18. Qiagen N.V.
17.19. Quidel Corporation
17.20. Rapid STD Testing by RSC Health, PA
17.21. Teco Diagnostics
17.22. Thermo Fisher Scientific, Inc.

List of Figures

FIGURE 1. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES HERPES MARKER TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA HERPES MARKER TESTING MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COMBINED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COMBINED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COMBINED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-1, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-1, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-1, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-2, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-2, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-2, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY IGG ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY IGG ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY IGG ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY IGM ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY IGM ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY IGM ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CONVENTIONAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CONVENTIONAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY WESTERN BLOT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY WESTERN BLOT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY SPECIALIZED CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY SPECIALIZED CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITAL LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITAL LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GOVERNMENT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GOVERNMENT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GOVERNMENT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INSTITUTIONAL TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INSTITUTIONAL TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INSTITUTIONAL TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 149. EUROPE HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 153. EUROPE HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 154. EUROPE HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 155. EUROPE HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPE HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 158. EUROPE HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. EUROPE HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 160. EUROPE HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 173. AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 175. AFRICA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. AFRICA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 177. AFRICA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 178. AFRICA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 179. AFRICA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. AFRICA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 181. AFRICA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 182. AFRICA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. AFRICA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 184. AFRICA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 200. ASEAN HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. ASEAN HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 202. ASEAN HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 203. ASEAN HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 204. ASEAN HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. ASEAN HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 206. ASEAN HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 207. ASEAN HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. ASEAN HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 209. ASEAN HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 210. GCC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GCC HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 212. GCC HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 213. GCC HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 214. GCC HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 215. GCC HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 216. GCC HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. GCC HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 218. GCC HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 219. GCC HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 220. GCC HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 221. GCC HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 234. BRICS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 236. BRICS HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. BRICS HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 238. BRICS HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 239. BRICS HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 240. BRICS HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. BRICS HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 242. BRICS HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 243. BRICS HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. BRICS HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 245. BRICS HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 246. G7 HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. G7 HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 248. G7 HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. G7 HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 250. G7 HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 251. G7 HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 252. G7 HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. G7 HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 254. G7 HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 255. G7 HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 256. G7 HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 257. G7 HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 258. NATO HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. NATO HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 260. NATO HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 261. NATO HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 262. NATO HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 263. NATO HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 264. NATO HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. NATO HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 266. NATO HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 267. NATO HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 268. NATO HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 269. NATO HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES HERPES MARKER TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 283. CHINA HERPES MARKER TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. CHINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 285. CHINA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 286. CHINA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 287. CHINA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2032 (USD MILLION)
TABLE 288. CHINA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 289. CHINA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. CHINA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 291. CHINA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 292. CHINA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 293. CHINA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2032 (USD MILLION)
TABLE 294. CHINA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Herpes Marker Testing market report include:

Abbott Laboratories
Abcam PLC
Bio-Diagnostics Ltd.
Bio-Rad Laboratories, Inc.
bioMerieux SA
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Luminex Corporation - A DiaSorin Company
Merck KGaA
Meridian Bioscience, Inc. by SD Biosensor and SJL Partners
Norgen Biotek Corporation
OneCare Media, LLC
Qiagen N.V.
Quidel Corporation
Rapid STD Testing by RSC Health, PA
Teco Diagnostics
Thermo Fisher Scientific, Inc.

Table Information

Report Attribute	Details
No. of Pages	183
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 571.01 Million
Forecasted Market Value ( USD ) by 2032	$ 854.1 Million
Compound Annual Growth Rate	7.0%
Regions Covered	Global
No. of Companies Mentioned	19

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3505EUR$3,939USD£3,044GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3781EUR$4,249USD£3,283GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5125EUR$5,759USD£4,450GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6201EUR$6,969USD£5,385GBP

Market Snapshot: Herpes Marker Testing Market Size and Trajectory

Scope & Segmentation of the Herpes Marker Testing Market

Key Takeaways for Decision-Makers

Tariff Impact: US Policy Changes on Diagnostic Supply Chains

Methodology & Data Sources

The Role of Herpes Marker Testing in Diagnostics

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Herpes Marker Testing - Global Strategic Business Report

HSV Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Sexually Transmitted Disease Diagnostics Market - Global Forecast 2026-2032

Sexually Transmitted Diseases Diagnostics Market - Global Forecast 2025-2032

Sexually Transmitted Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)